Shionogi Set To Acquire R&D Partner Tetra After Raising Stake

Deal Hinges On Imminent Alzheimer’s Results

Japanese firm sets stage to acquire US bioventure after it raises stake just ahead of key readout for lead asset.

Alzheimers_677117191_Atthapon-Raksthaput_1200.jpg
Shionogi Eyes Alzheimer's Via Possible Tetra Deal • Source: Shutterstock

More from Neurological

More from Therapy Areas